Paraxylene separation process
US-9850186-B2 · Dec 26, 2017 · US
US10626071B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10626071-B2 |
| Application number | US-201815961085-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 24, 2018 |
| Priority date | Feb 10, 2011 |
| Publication date | Apr 21, 2020 |
| Grant date | Apr 21, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Compounds and compositions are provided that inhibit histone deacylase activity and which expand renal progenitor cell populations and improve kidney function in a damaged kidney. Methods of use of the compounds and compositions are provided.
Opening claim text (preview).
What is claimed is: 1. A composition comprising: a compound having the formula: wherein R is S; R1 is —OR5 where R5 is H or CH 3 ; R2 is phenyl; and R3 is 3 methylene groups, or a pharmaceutically acceptable salt thereof, in an amount effective to increase renal progenitor cell production in a kidney of a patient; and a pharmaceutically-acceptable excipient. 2. The composition of claim 1 , wherein the compound has the formula: or a pharmaceutically acceptable salt thereof. 3. The composition of claim 1 , comprising a cyclodextrin complexed with the compound. 4. The composition of claim 1 , wherein the compound is 4-(phenylthio)butanoic acid. 5. A method, comprising administering the composition of claim 1 to a subject. 6. A method, comprising administering the composition of claim 2 to a subject. 7. A method, comprising administering the composition of claim 3 to a subject. 8. A method, comprising administering the composition of claim 4 to a subject. 9. A method of increasing renal progenitor cell production in a kidney of a patient, the method comprising administering the composition of claim 1 to the patient. 10. A method of increasing renal progenitor cell production in a kidney of a patient, the method comprising administering the composition of claim 2 to the patient. 11. A method of increasing renal progenitor cell production in a kidney of a patient, the method comprising administering the composition of claim 3 to the patient. 12. A method of increasing renal progenitor cell production in a kidney of a patient, the method comprising administering the composition of claim 4 to the patient.
the carbon skeleton containing six-membered aromatic rings · CPC title
having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton · CPC title
of the kidneys · CPC title
Simulated moving beds · CPC title
the nitrogen atom of the amino group being further bound to carbon atoms of six-membered aromatic rings · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.